Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells

Experimental Neurology

Volumn 267, Issue , 2015, Pages 152-164

  Matsushita, Takashi ^a,b   Lankford, Karen L ^a   Arroyo, Edgardo J ^a   Sasaki, Masanori ^a,b   Neyazi, Milad ^a,c   Radtke, Christine ^a,c   Kocsis, Jeffery D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood spinal cord barrier; Mesenchymal stem cell; Pericytes; Spinal cord injury

Indexed keywords

ANTIGEN; ENDOTHELIAL BARRIER ANTIGEN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; ENDOTHELIAL BARRIER ANTIGEN, RAT; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE ANTIGEN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SPINAL CORD BARRIER; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; EX VIVO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; MEMBRANE DAMAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROVASCULATURE; NONHUMAN; PERICYTE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECTROPHOTOMETRY; SPINAL CORD INJURY; ANIMAL; BIOLOGICAL THERAPY; BLOOD BRAIN BARRIER; DISEASE MODEL; ENDOTHELIUM CELL; EXPLORATORY BEHAVIOR; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; TIME; TRANSGENIC RAT;

ANIMALS; ANTIGENS, SURFACE; BLOOD-BRAIN BARRIER; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EXPLORATORY BEHAVIOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LOCOMOTION; MALE; MESENCHYMAL STROMAL CELLS; MICROVESSELS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SPINAL CORD INJURIES; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 84925272832     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.03.001     Document Type: Article

References (49)

1. Al Ahmad A., Taboada C.B., Gassmann M., Ogunshola O.O. Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J. Cereb. Blood Flow Metab. 2011, 31(2):693-705.
2. Armulik A., Genové G., Mäe M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., Johansson B.R., Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 2010, 468(7323):557-561.
3. Bartanusz V., Jezova D., Alajajian B., Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann. Neurol. 2011, 70(2):194-206.
4. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 1995, 12(1):1-21.
5. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., Woodruff T.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133(Pt 2):433-447.
6. Byun J.S., Kwak B.K., Kim J.K., Jung J., Ha B.C., Park S. Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model: comparison of intra-arterial and intravenous infusion using MRI and histological analysis. J. Korean Neurosurg. Soc. 2013, 54(6):467-476.
7. Carmeliet P., Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann. N. Y. Acad. Sci. 2000, 902:249-262. (discussion 262-264).
8. Cohen D.M., Patel C.B., Ahobila-Vajjula P., Sundberg L.M., Chacko T., Liu S.J., Narayana P.A. Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed. 2009, 22(3):332-341.
9. Danchuk S., Ylostalo J.H., Hossain F., Sorge R., Ramsey A., Bonvillain R.W., Lasky J.A., Bunnell B.A., Welsh D.A., Prockop D.J., Sullivan D.E. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6. Stem Cell Res. Ther. 2011, 2(3):27.
10. Daneman R., Zhou L., Kebede A.A., Barres B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468(7323):562-566.
11. Dore-Duffy P., Owen C., Balabanov R., Murphy S., Beaumont T., Rafols J.A. Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc. Res. 2000, 60(1):55-69.
12. Figley S.A., Khosravi R., Legasto J.M., Tseng Y.F., Fehlings M.G. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J. Neurotrauma 2014, 31(6):541-552.
13. Gao J., Dennis J.E., Muzic R.F., Lundberg M., Caplan A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169(1):12-20.
14. Ghabriel M.N., Zhu C., Hermanis G., Allt G. Immunological targeting of the endothelial barrier antigen (EBA) in vivo leads to opening of the blood-brain barrier. Brain Res. 2000, 878(1-2):127-135.
15. Göritz C., Dias D.O., Tomilin N., Barbacid M., Shupliakov O., Frisén J.A. Pericyte origin of spinal cord scar tissue. Science 2011, 333(6039):238-242.
16. Hamilton N.B., Attwell D., Hall C.N. Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front. Neuroenerg. 2010, 2. (pii: 5). 10.3389/fnene.2010.00005.
17. Hatzi V.I., Laskaratou D.A., Mavragani I.V., Nikitaki Z., Mangelis A., Panayiotidis M.I., Pantelias G.E., Terzoudi G.I., Georgakilas A.G. Non-targeted radiation effects in vivo: a critical glance of the future in radiobiology. Cancer Lett. 2015, 356(1):34-42.
18. Horner P.J., Popovich P.G., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. II. Permeability after intraspinal fetal transplantation. Exp. Neurol. 1996, 142(2):226-243.
19. Kaptanoglu E., Okutan O., Akbiyik F., Solaroglu I., Kilinc A., Beskonakli E. Correlation of injury severity and tissue Evans blue content, lipid peroxidation and clinical evaluation in acute spinal cord injury in rats. J. Clin. Neurosci. 2004, 11(8):879-885.
20. Kassis I., Grigoriadis N., Gowda-Kurkalli B., Mizrachi-Kol R., Ben-Hur T., Slavin S., Abramsky O., Karussis D. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 2008, 65(6):753-761.
21. Kilkenny C., Browne W., Cuthill I.C. Emerson M, Altman DG; NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo experiments: the ARRIVE guidelines. J. Gene Med. 2010, 12(7):561-563.
22. Kilpinen L., Impola U., Sankkila L., Ritamo I., Aatonen M., Kilpinen S., Tuimala J., Valmu L., Levijoki J., Finckenberg P., Siljander P., Kankuri E., Mervaala E., Laitinen S. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J. Extracell Vesicles 2013, 10:2. 10.3402/jev.v2i0.21927.
23. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., Salto-Tellez M., Timmers L., Lee C.N., El Oakley R.M., Pasterkamp G., de Kleijn D.P., Lim S.K. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010, 4(3):214-222.
24. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., Semprun-Prieto L., Delafontaine P., Prockop D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5(1):54-63.
25. Lemmon V.P., Ferguson A.R., Popovich P.G., Xu X.M., Snow D.M., Igarashi M., Beattie C.E., Bixby J.L. Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments. J. Neurotrauma 2014, 31(15):1354-1361. MIASCI Consortium.
26. Lin B., Ginsberg M.D. Quantitative assessment of the normal cerebral microvasculature by endothelial barrier antigen (EBA) immunohistochemistry: application to focal cerebral ischemia. Brain Res. 2000, 865(2):237-244.
27. Matthes S.M., Reimers K., Janssen I., Liebsch C., Kocsis J.D., Vogt P.M., Radtke C. Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration. Biomed. Res. Int. 2013, 573169.
28. Nakano N., Nakai Y., Seo T.B., Homma T., Yamada Y., Ohta M., Suzuki Y., Nakatani T., Fukushima M., Hayashibe M., Ide C. Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats. PLoS One 2013, 8(9):e73494.
29. Noble L.J., Wrathall J.R. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 1989, 482:57-66.
30. Noubade R., del Rio R., McElvany B., Zachary J.F., Millward J.M., Wagner D.D., Offner H., Blankenhorn E.P., Teuscher C. Von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. Am. J. Pathol. 2008, 173(3):892-900.
31. Ohshima M., Taguchi A., Tsuda H., Sato Y., Yamahara K., Harada-Shiba M., Miyazato M., Ikeda T., Iida H., Tsuji M. Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia. Brain Dev. 2015, 37(4):376-386.
32. Osaka M., Honmou O., Murakami T., Nonaka T., Houkin K., Hamada H., Kocsis J.D. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 2010, 1343:226-235.
33. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 1996, 142(2):258-275.
34. Quertainmont R., Cantinieaux D., Botman O., Sid S., Schoenen J., Franzen R. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 2012, 7(6):e39500.
35. Randi A.M., Laffan M.A., Starke R.D. Von Willebrand factor, angiodysplasia and angiogenesis. Mediterr. J. Hematol. Infect. Dis. 2013, 5(1):e2013060.
36. Rastogi S., Boylan M., Wright E.G., Coates P.J. Interactions of apoptotic cells with macrophages in radiation-induced bystander signaling. Radiat. Res. 2013, 179(2):135-145.
37. Roddy G.W., Oh J.Y., Lee R.H., Bartosh T.J., Ylostalo J., Coble K., Rosa R.H., Prockop D.J. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells 2011, 29(10):1572-1579.
38. Rosenstein J.M., Krum J.M., Sternberger L.A., Pulley M.T., Sternberger N.H. Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis. Brain Res. Dev. Brain Res. 1992, 66(1):47-54.
39. Ryan L.A., Smith R.W., Seymour C.B., Mothersill C.E. Dilution of irradiated cell conditioned medium and the bystander effect. Radiat. Res. 2008, 169(2):188-196.
40. Sasaki M., Radtke C., Tan A.M., Zhao P., Hamada H., Houkin K., Honmou O., Kocsis J.D. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J. Neurosci. 2009, 29(47):14932-14941.
41. Starke R.D., Ferraro F., Paschalaki K.E., Dryden N.H., McKinnon T.A., Sutton R.E., Payne E.M., Haskard D.O., Hughes A.D., Cutler D.F., Laffan M.A., Randi A.M. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011, 117(3):1071-1080.
42. Suidan G.L., Brill A., De Meyer S.F., Voorhees J.R., Cifuni S.M., Cabral J.E., Wagner D.D. Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice. Arterioscler. Thromb. Vasc. Biol. 2013, 33(9):2112-2120.
43. Toyama K., Honmou O., Harada K., Suzuki J., Houkin K., Hamada H., Kocsis J.D. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp. Neurol. 2009, 216(1):47-55.
44. Wang N., Li Q., Zhang L., Lin H., Hu J., Li D., Shi S., Cui S., Zhou J., Ji J., Wan J., Cai G., Chen X. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One 2012, 7(8):e43768.
45. Whetstone W.D., Hsu J.Y., Eisenberg M., Werb Z., Noble-Haeusslein L.J. Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J. Neurosci. Res. 2003, 74(2):227-239.
46. Winkler E.A., Bell R.D., Zlokovic B.V. Central nervous system pericytes in health and disease. Nat. Neurosci. 2011, 14(11):1398-1405.
47. Xin H., Li Y., Buller B., Katakowski M., Zhang Y., Wang X., Shang X., Zhang Z.G., Chopp M. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 2012, 30(7):1556-1564.
48. Xin H., Li Y., Liu Z., Wang X., Shang X., Cui Y., Zhang Z.G., Chopp M. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 2013, 31(12):2737-2746.
49. Yilmaz G., Vital S., Yilmaz C.E., Stokes K.Y., Alexander J.S., Granger D.N. Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature. Stroke 2011, 42(3):806-811.